Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes
Laurent Castéra(Université Paris Cité), Franck Letourneur(Inserm), Amine Toubal(Centre National de la Recherche Scientifique), N. Neveux(Hôpital Cochin), Anaïs Vallet‐Pichard(Assistance Publique – Hôpitaux de Paris), Sébastien Czernichow(Inserm), Zouriatou Gouda, Tiphaine Vidal-Trécan(Assistance Publique – Hôpitaux de Paris), Jean-Michel Corréas(Assistance Publique – Hôpitaux de Paris), Béatrice Parfait(Délégation Paris 5), Benoît Girard(Centre National de la Recherche Scientifique), Philippe Garteiser(Oklahoma Medical Research Foundation), Pauline Manchon(Inserm), Dominique Valla(Inserm), Ouassila Zatout, Krishna Bhavsar, Pierre Bédossa(Régie Autonome des Transports Parisiens (France)), Étienne Larger(Inserm), Dominique Roulot(Université Sorbonne Paris Nord), Jean–François Gautier(University of Arizona), Michel Vidaud(Institut de Soudure), Cédric Laouenan(Université Claude Bernard Lyon 1), Adel Hammoutène(Inserm), Emmanuel Cosson(Hôpital Jean-Verdier), Catherine Postic(Centre National de la Recherche Scientifique), Valérie Paradis(Inserm), Estefania Gonzalez Montpetit, Delphine Bachelet(Assistance Publique – Hôpitaux de Paris), Agnès Lehuen(Centre National de la Recherche Scientifique), Pauline Soulard(Assistance Publique – Hôpitaux de Paris), Miassa Slimani, Stanislas Pol(Université Paris Cité), Bernard E. Van Beers(Cliniques Universitaires Saint-Luc), Estelle Marcault, Gwenaël Pagé(Université de Picardie Jules Verne), Blandine Fruchet, Djamila Bellili, Meriam Meziani, Ouarda Bessadi, Fatima Zohra Djelouat, Dahia Sekour, Basma Basli-Baillet Jimmy Mullaert, Nassima Si-Mohammed, Miguel Albuquerque, Vanessa Legrand, Ludovic Roy, Manon Sens, Sabrina Doblas(Oklahoma Medical Research Foundation), Camille Rousseau, Charlène Da Silveira
Cited by 52
Related Papers
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
|Science|2009|1.5k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
BMI in relation to sperm count: an updated systematic review and collaborative meta-analysis
|Human Reproduction Update|2012|655